We observed that endogenous overexpression of ECHS1 could reduce Oxaliplatin-induced apoptosis of CRC cells, and then we wanted to explore whether endogenous ECHS1 affected the drug sensitivity of cells. This evidence concerns the gene ECHS1 and colorectal carcinoma.